BACKGROUND/AIMS: @entity63 includes a wide clinical spectrum ranging from mild to severe forms. This study aimed to determine the factors that are related to the occurrence of severe @entity63 . METHODS: This multicenter study was conducted retrospectively in Korea. The @entity1 were divided into mild and severe groups. This study surveyed clinical characteristics, blood tests, endoscopic findings, and imaging studies. RESULTS: In the comparison of comorbidities, the severe group had a higher ratio of @entity740 than the mild group (p=0.001). In the blood test, the severe group had a reduced number of platelets (p=0.018) and a higher C-reactive protein value (p=0.001). The severe group had a higher ratio of involvement of the right colon (p=0.026). The Eastern Cooperative Oncology Group (ECOG) performance status score of the @entity1 showed that the severe group had higher scores than the mild group (p=0.003). A multivariate analysis showed that @entity740 and high ECOG performance status scores were significant risk factors. CONCLUSIONS: If @entity1 diagnosed with @entity63 are also treated for @entity740 or have poor performance status, more attention and early intervention are necessary.

Predictive Factors for Severe Outcomes in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity740 :: ('MESH:D051436', 'Disease') :: ['chronic kidney disease'] @entity63 :: ('MESH:D007511', 'Disease') :: ['ischemic colitis', 'Ischemic colitis']
@entity63 :: (MESH:D007511,Disease) :: ['Ischemic Colitis']
